Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults
Clinical trial NCT03565315 · TERMINATED
Trial details
- NCT number
- NCT03565315
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2019-03-04
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.